{
  "context": {
    "rules": [
      "Rule1: Provided that the drug formula is effective, if either the measuring device is not calibrated or the production line is not maintained, then the manufacturing license becomes suspended.",
      "Rule2: Whenever the chemical composition is stable, the FDA application is approved.",
      "Rule3: If the active ingredient is pure, then the excipient is soluble.",
      "Rule4: In the event that the deviation is investigated, if it is not the case that the excipient being soluble leads to a stable chemical composition, then the batch is not rejected.",
      "Rule5: Either the synthesis method is optimized or the purification technique is improved.",
      "Rule6: Whenever the purification technique is improved, the drug formula becomes effective.",
      "Rule7: The production method is tested or the manufacturing process is validated.",
      "Rule8: Either technology transfer is licensed, or the new formulation is patented, or optimizing the synthesis method leads to an effective drug formula.",
      "Rule9: Provided that the regulatory submission is approved, either manufacturing rights are acquired or technology transfer is not licensed.",
      "Rule10: If the analytical method is validated, then, under the condition that either the measuring device is not calibrated or the production line is not maintained, the manufacturing license is suspended.",
      "Rule11: The clean room is certified or the analytical method is validated.",
      "Rule12: Either the novel delivery system is developed or the bioavailability is enhanced.",
      "Rule13: Whenever the bioavailability is enhanced, the drug formula is effective.",
      "Rule14: Under the condition that the conference presentation is presented, either the research paper is published or the development of the novel delivery system results in an effective drug formula.",
      "Rule15: If the manufacturing process is validated, then, if the FDA application is not approved, the drug component is approved.",
      "Rule16: Provided that the journal article is submitted, either the research paper is published or the novel delivery system being developed leads to an effective drug formula.",
      "Rule17: The intellectual property being protected means that the trade secret is not confidential.",
      "Rule18: If the patent is registered, then the trade secret is not confidential.",
      "Rule19: Whenever the patent application is filed, the intellectual property is protected.",
      "Rule20: The patent application is filed or the patent rights are granted.",
      "Rule21: The patent rights being granted results in the patent being registered.",
      "Rule22: If the quality system is compliant, then the equipment being sterile implies that the raw material is not contaminated.",
      "Rule23: If the measuring device is calibrated, then, provided that the laboratory is certified, the FDA application is approved.",
      "Rule24: Under the condition that the production line is maintained, if the laboratory is certified, then the FDA application is approved.",
      "Rule25: If it is not the case that the excipient being soluble leads to a stable chemical composition, then the batch is rejected.",
      "Rule26: If it is not the case that the production method being tested leads to the situation where, if the FDA application is not approved, the drug component is approved, then the raw material is contaminated.",
      "Rule27: Whenever it is not the case that the production method being tested implies that, if the FDA application is not approved, the drug component is approved, the equipment is sterile.",
      "Rule28: If neither the conference presentation is presented nor the journal article is submitted, then the trade secret is confidential.",
      "Rule29: Provided that either the measuring device is not calibrated or the production line is not maintained, the manufacturing license is not suspended.",
      "Rule30: In the event that the drug formula is not effective, the side effect is toxic.",
      "Rule31: If the FDA application is not approved, then the drug component is not approved."
    ],
    "facts": [
      "Fact1: The active ingredient is pure.",
      "Fact2: The deviation is investigated.",
      "Fact3: The regulatory submission is approved.",
      "Fact4: The quality system is compliant.",
      "Fact5: The laboratory is certified.",
      "Fact6: The side effect is not toxic.",
      "Fact7: The new formulation is not patented.",
      "Fact8: The manufacturing rights are not acquired.",
      "Fact9: The clean room is not certified.",
      "Fact10: The research paper is not published."
    ]
  },
  "question": "The FDA application is approved."
}